Pancreatic Cancer Monitor Profile      Number 485086 CPT 82378; 84275; 86301 Test Includes CA 19-9, serial monitor report; carcinoembryonic antigen (CEA), serial monitor report; lipid-associated sialic acid (LASA), serial monitor report Special Instructions The account must submit the patient's Social Security number to monitor. State on the request form whether the patient is a smoker or nonsmoker. Values obtained with different assay methods should not be used interchangeably in serial testing. It is recommended that only one assay method be used consistently to monitor each patient's course of therapy. Specimen Serum Volume 4 mL Minimum Volume 2 mL Container Red-top tube or gel-barrier tube Collection If a red-top tube is used, transfer separated serum to a plastic transport tube. Storage Instructions Refrigerate Causes for Rejection Hemolysis; whole blood specimen Use Monitor the course of pancreatic cancer, patient response to treatment, and disease recurrence Limitations This profile should not be used as a diagnostic or screening test for cancer. The LASA procedure may be considered by Medicare and other carriers as investigational and, therefore, may not be payable as a covered benefit for patients. Methodology See individual tests.

Copyright © 2007 by Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved